Antidepressants Not Working? Next Steps for Depression Care
If antidepressants are not working, or medication and therapy have not provided enough relief, there can still be useful treatment options for depression. The next step may involve improving an existing treatment, addressing something the earlier plan missed, or considering an intervention such as TMS, esketamine, or ECT. Which direction makes sense depends on the diagnosis, earlier treatment trials, current severity, safety, and your preferences. No option can guarantee recovery, but disappointing results do not prove that every reasonable option has been exhausted.
It is understandable to feel wary of another recommendation. You do not have to feel optimistic before asking for help. A useful conversation can begin with a practical question: “What would make this next plan meaningfully different from what I have already tried?”
Start with the support you need now
If depression is getting worse, tell a clinician promptly rather than waiting until a planned treatment review. If you have thoughts of suicide or are struggling to stay safe, call or text 988 in the United States. For immediate physical danger or a life-threatening emergency, call 911 or seek emergency care. An upcoming consultation or TMS course is not a substitute for urgent help.
For ongoing depression treatment, explain what daily life currently requires of you. Eating, sleeping, caring for children, attending work, and managing medications may need attention while a longer treatment decision is being made. Ask the clinician how much support is appropriate now, including whether a more intensive level of care should be considered.
If you want a trusted person involved, decide what role would help: remembering questions, collecting records, arranging transportation, or joining part of a visit with your permission. Support should make the plan easier to follow while preserving your voice in decisions.
When antidepressants are not working: review the treatment history
“Nothing worked” can describe several different situations. A treatment might have helped one symptom, caused unacceptable side effects, become unaffordable, or ended before an adequate trial was possible. Reviewing those differences can change the next recommendation.
Treatment-resistant depression is commonly defined by a lack of remission after at least two adequate antidepressant trials, although definitions vary. A clinician needs to confirm dose, duration, and adherence before applying that description. The label describes a clinical treatment problem; it does not measure effort, character, or willingness to recover.
Ask the reviewing clinician to consider whether the original diagnosis still fits. Medical conditions, other medications, substance use, and coexisting mental health problems can affect the picture. A history suggesting bipolar disorder, for example, requires a different assessment from assuming every depressive episode is unipolar major depression.
You can organize your history into three columns: what was tried, what changed, and why it ended. Include treatments that helped briefly. Avoid filling gaps with guesses; uncertainty is useful information too.
Treatment-resistant depression options to discuss
The following are discussion options, not a recommended sequence for everyone. Availability at a particular clinic, eligibility, and insurance coverage must be checked separately.
Reviewing or changing medication
A prescriber may recommend adjusting an existing treatment, switching medication, or adding another medication. Each strategy has possible benefits, adverse effects, interactions, and monitoring requirements. The reasoning should address your actual history, including anything that helped and any side effects you want to avoid.
Ask what the new approach is intended to change and when benefit and tolerability will be reviewed. Do not stop, restart, or combine medications on your own. Withdrawal effects or a return of symptoms can complicate the picture.
Revisiting psychotherapy
An earlier experience with therapy does not establish that every form of psychotherapy will have the same result. The approach, treatment goals, consistency of visits, and fit with your needs all deserve discussion. Evidence-based approaches for depression include cognitive behavioral therapy and interpersonal therapy. Psychotherapy may be used with medication or other interventions.
Sophroneo’s therapy and medication services provide a starting point for asking what approaches are actually available. A useful question is, “What would we work on, and how would we notice whether it was helping?” You should understand the proposed work, not just the name of the therapy.
TMS when earlier depression treatment has not helped enough
Transcranial magnetic stimulation uses magnetic pulses delivered from a coil outside the head to stimulate brain regions involved in mood. You remain awake, and the procedure generally does not require anesthesia. It can be considered for appropriate people whose depression has not improved sufficiently with earlier treatment.
TMS still involves a substantial commitment to repeated visits. Scalp discomfort and headaches can occur, and a seizure is a rare but serious risk. Screening for implanted devices, neurological history, medication changes, and other safety concerns is necessary. The FDA-cleared indication depends on the particular device and protocol; clearance alone does not determine personal suitability.
When reviewing Sophroneo’s TMS service, ask why the clinician recommends it for your situation, how it would fit with existing care, and what would happen if improvement were limited.
Spravato (esketamine): supervised treatment for depression
Spravato is an esketamine nasal spray. The FDA prescribing information allows its use for treatment-resistant depression in adults either alone or with an oral antidepressant. A separate indication for depressive symptoms in adults with major depression and acute suicidal ideation or behavior requires an oral antidepressant.
Spravato is administered under direct supervision through a restricted safety program, with monitoring for at least two hours. Risks include sedation, dissociation, breathing problems, increased blood pressure, and abuse or misuse. Patients need a ride home and must not drive until the next day after restful sleep. It is not a take-home nasal spray.
The medication has not been shown to prevent suicide or reduce suicidal ideation or behavior, and it does not replace hospitalization when needed. Its FDA approval also does not apply to ketamine infusions, oral ketamine, or compounded nasal products.
Sophroneo’s Spravato service information can help you identify whom to ask about an evaluation. For the practical commitment, consider the entire supervised visit and transportation arrangements described in the guide to planning a Spravato treatment day.
Discussing ECT when appropriate
Electroconvulsive therapy uses an electrical stimulus to produce a controlled seizure under anesthesia. It can be considered for severe depression that has not responded to other treatment, or when a rapid response is needed because the illness is life-threatening. Its risks and practical demands differ from TMS, including anesthesia and potential memory problems. A specialist should explain those tradeoffs for the individual situation.
NIMH’s discussion below explains how brain stimulation treatments fit within broader psychiatric care. It is useful preparation for comparing TMS and ECT with a qualified team; it cannot establish which procedure is right for a particular person.
Compare the demands as well as the possible benefits
A treatment is easier to evaluate when the clinician helps you compare the same questions across options. Ask about the expected visits, transportation, side effects, out-of-pocket costs, and how quickly a meaningful review can occur. Also ask what is known about people with a treatment history similar to yours.
Try to distinguish three kinds of statements: a finding from a study, a clinic’s own measured results, and a prediction about you. They are not interchangeable. If a success rate is quoted, ask what success meant, who was included, and how long people were followed. A percentage without those details cannot tell you what to expect.
Your priorities belong in the comparison. You may be particularly concerned about sedation, work interruptions, medication effects, or the burden of frequent appointments. Tell the clinician which tradeoffs feel manageable and which would make a plan unrealistic. You can ask for time to review a nonurgent recommendation or obtain a second opinion.
Make room for progress that matters to you
Agree on a small set of goals before the next treatment begins. Examples might include preparing breakfast, participating in a conversation, completing a routine task, or feeling some interest in a previously meaningful activity. These are suggested tracking goals, not predictions of what treatment will achieve.
Use them alongside the clinician’s symptom assessments. The article on recognizing meaningful progress in anhedonia can help you describe changes in interest and enjoyment without treating one good or difficult day as the whole story.
Set a review date and ask what will happen at it. A useful review considers symptom change, daily function, side effects, and whether the treatment remains acceptable. If the result is disappointing, the plan should explain the next decision rather than leaving you unsure whether to continue indefinitely.
Leave with one concrete next step
You do not need to decide among every treatment at once. The next useful step might be obtaining records, arranging a second assessment, clarifying a medication history, or discussing a specialist referral. Write down who will do what and when you should hear back.
If you would like to explore care with Sophroneo, use the practice’s contact information to ask about an evaluation and the relevant services. Confirm the actual treatment location, scheduling, and coverage before making a commitment.
Hope does not require a promise that the next treatment will work. It can begin with a more complete assessment, a choice you understand, and a team willing to review the plan with you. Continued symptoms deserve continued attention, including support while those decisions are made.
This article is general education and does not replace an individualized treatment assessment.
Frequently Asked Questions
Does trying TMS mean I have to give up medication or therapy?
No. TMS may be included in a plan that also involves psychotherapy, medication, or both. Discuss changes with the clinicians responsible for your care rather than stopping existing treatment yourself.
Is Spravato the same treatment as an IV ketamine infusion?
No. Spravato contains esketamine and is a specifically approved nasal product with defined indications and a restricted safety program. Ketamine infusions and compounded ketamine products are different formulations, and Spravato’s approval does not extend to them.
What if I want a second opinion before starting another treatment?
You can ask for an explanation of the recommendation and seek a second opinion. Bring records of prior treatment and a list of the questions the first consultation did not resolve. If symptoms create an urgent safety concern, seek prompt help while the longer-term decision is being made.
How can I help someone who has lost confidence in treatment?
Ask what kind of help they would welcome, such as company at a visit, help organizing records, or practical support with daily tasks. Avoid promising that a particular treatment will work. If they are in crisis, call or text 988 in the United States; call 911 for immediate physical danger or a life-threatening emergency.
Comments